FDA Inspection 1304382 — Guardian Drug Co. Inc.
The FDA completed an inspection of Guardian Drug Co. Inc. on January 16, 2026 in Dayton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 16, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dayton, NJ (United States)